Literature DB >> 10512162

Functional CD32 molecules on human NK cells.

P A Morel1, L K Ernst, D Metes.   

Abstract

Human NK cells are large granular lymphocytes that kill neoplastic or virally infected targets using perforin-dependent mechanisms. CD16 or FcgammaRIII is one of the cell surface molecules that can trigger the killing machinery following binding of the Fc portion of IgG to the receptor: a mechanism known as antibody dependent cell-mediated cytotoxicity (ADCC). We have recently shown that some individuals express an additional FcgammaR on their NK cells, CD32 or FcgammaRII. This receptor has now been characterized at the molecular, biochemical and functional level. The present review outlines our findings to date on the features of this novel receptor. These findings suggest that the presence of a functional FcgammaRII on the surface of NK cells could have important clinical consequences in both tumor immunotherapy and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512162     DOI: 10.3109/10428199909145704

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.

Authors:  Jianbiao Zhou; Wee-Joo Chng
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

3.  FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.

Authors:  Amy K Erbe; Wei Wang; Jacob Goldberg; Mikayla Gallenberger; KyungMann Kim; Lakeesha Carmichael; Dustin Hess; Eneida A Mendonca; Yiqiang Song; Jacquelyn A Hank; Su-Chun Cheng; Sabina Signoretti; Michael Atkins; Alexander Carlson; James W Mier; David J Panka; David F McDermott; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2016-10-14       Impact factor: 12.531

Review 4.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

5.  Expression of Fc Fragment Receptors of Immunoglobulin G (FcγRs) in Rat Hepatic Stellate Cells.

Authors:  Hong Shen; Manna Zhang; Kelly Kaita; Gerald Y Minuk; Julia Rempel; Yuewen Gong
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 6.  Immunotherapy of cancer.

Authors:  Hossein Borghaei; Mitchell R Smith; Kerry S Campbell
Journal:  Eur J Pharmacol       Date:  2009-10-20       Impact factor: 4.432

Review 7.  Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.

Authors:  Jop Jans; Marloes Vissers; Jacco G M Heldens; Marien I de Jonge; Ofer Levy; Gerben Ferwerda
Journal:  Rev Med Virol       Date:  2013-11-14       Impact factor: 6.989

8.  Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.

Authors:  Xueying Fan; Liyan Zhu; Hua Liang; Zhe Xie; Xiangbo Huang; Shuo Wang; Tao Shen
Journal:  Retrovirology       Date:  2016-11-04       Impact factor: 4.602

Review 9.  Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies.

Authors:  Maxim Shevtsov; Gabriele Multhoff
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

Review 10.  NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy.

Authors:  Wei Wang; Amy K Erbe; Jacquelyn A Hank; Zachary S Morris; Paul M Sondel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.